Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease

ClinicalTrials.gov ID: NCT02433158

Public ClinicalTrials.gov record NCT02433158. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 11:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension Study to Evaluate the Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open label extension study in subjects with Sickle Cell Disease (SCD) who have completed the double blind Phase 3 study (B5201002).

Study identification

NCT ID
NCT02433158
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlycoMimetics Incorporated
Industry
Enrollment
154 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 16, 2015 (Actual)
Primary completion
Nov 15, 2019 (Actual)
Completion
Nov 15, 2019 (Actual)
Last update posted
Feb 10, 2021

2015 – 2019

United States locations

U.S. sites
85
U.S. states
22
U.S. cities
31
Facility City State ZIP Site status
University of South Alabama Women's and Children's Hospital Mobile Alabama 36604 —
Arkansas Children's Hospital Research Pharmacy Little Rock Arkansas 72202 —
Arkansas Children's Hospital Little Rock Arkansas 72202 —
UC Davis Medical Center Main Hospital Sacramento California 95817 —
University of California Davis Medical Center Sacramento California 95817 —
Howard University Center for Sickle Cell disease Washington D.C. District of Columbia 20001 —
MedStar Health Research Institute Washington D.C. District of Columbia 20010 —
Howard University Hospital Washington D.C. District of Columbia 20060 —
Golisano Childrens Hospital of Southwest Florida Fort Myers Florida 33908 —
Jackson Memorial Hospital Miami Florida 33136 —
University of Miami Miami Florida 33136 —
St. Mary's Medical Center West Palm Beach Florida 33407 —
Children's Healthcare of Atlanta Aflac Cancer and Blood Disorders Center: Atlanta Georgia 30303 —
Grady Health System Atlanta Georgia 30303 —
Children's Healthcare of Atlanta Aflac Cancer and Blood Disorders Center: Atlanta Georgia 30322 —
Emory Children's Center Atlanta Georgia 30322 —
Children's Healthcare of Atlanta Aflac Cancer and Blood Disorders Center/ Atlanta Georgia 30342 —
Children's Healthcare of Atlanta: Scottish Rite Campus Atlanta Georgia 30342 —
Memorial Family Medicine Center Savannah Georgia 31404 —
Memorial Health University Medical Center Savannah Georgia 31404 —
The University of Chicago/Comer Children's Hospital Chicago Illinois 60637 —
University of Chicago, Investigational Drug Service Pharmacy Chicago Illinois 60637 —
University of Maryland Medical System Investigational Pharmacy Baltimore Maryland 21201 —
University of Maryland Medical System Baltimore Maryland 21201 —
Johns Hopkins Department of Medicine Clinical Trials Unit Baltimore Maryland 21205 —
The Johns Hopkins University School of Medicine Baltimore Maryland 21205 —
The Johns Hopkins Hospital Department of Pharmacy Services Baltimore Maryland 21287-6180 —
Johns Hopkins Medicine Baltimore Maryland 21287 —
Boston Children's Hospital Boston Massachusetts 02115 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Center for Clinical Investigation, Brigham and Women's Hospital Boston Massachusetts 02115 —
Investigational Drug Services Boston Massachusetts 02115 —
Children's Hospital of Michigan Detroit Michigan 48201 —
University of Mississippi Medical Center - Outpatient Clinical Research Unit Jackson Mississippi 39216 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Center for Outpatient Health St Louis Missouri 63108 —
Barnes-Jewish Hospital Department of Pharmacy St Louis Missouri 63110 —
Barnes-Jewish Hospital St Louis Missouri 63110 —
Center for Advanced Medicine St Louis Missouri 63110 —
Washington University School of Medicine St Louis Missouri 63110 —
Bristol Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital New Brunswick New Jersey 08901 —
Rutgers-Robert Wood Johnson Medical School New Brunswick New Jersey 08901 —
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 —
Kings County Hospital Center Brooklyn New York 11203 —
State University of New York (SUNY) Downstate Medical Center Brooklyn New York 11203 —
SUNY Downstate Medical Center University Hospital of Brooklyn Brooklyn New York 11203 —
Columbia University Medical Center Research Pharmacy New York New York 10032 —
MS CHONY Pediatric Emergency Department New York New York 10032 —
MS CHONY Pediatric Hematology/Oncology Unit New York New York 10032 —
Jacobi Medical Center The Bronx New York 10461 —
Duke University Hospital, Investigational Drug Service Durham North Carolina 27710 —
Duke University Medical Center Durham North Carolina 27710 —
East Carolina University Brody School of Medicine Greenville North Carolina 27834 —
East Carolina University, Brody School of Medicine Greenville North Carolina 27834 —
Leo W. Jenkins Cancer Center Greenville North Carolina 27834 —
Vidant Medical Center Greenville North Carolina 27834 —
University of Cincinnati - Hoxworth Building Cincinnati Ohio 45219 —
University of Cincinnati Medical Center / Investigational Pharmacy Cincinnati Ohio 45219 —
University of Cincinnati Medical Center / Research Office Cincinnati Ohio 45219 —
University of Cincinnati Medical Center Cincinnati Ohio 45219 —
University of Cincinnati Physicians Company LLC Cincinnati Ohio 45219 —
UC Health Ridgeway Hospital Cincinnati Ohio 45229 —
The Ohio State University Investigational Drug Services Columbus Ohio 43203 —
The Ohio State University Wexner Center East Columbus Ohio 43203 —
The Ohio State University James Comprehensive Cancer Hospital & Solove Research Institute Columbus Ohio 43210 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
UPMC Presbyterian Pittsburgh Pennsylvania 15213 —
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 —
Hasbro Children's Hospital Providence Rhode Island 02903 —
Rhode Island Hospital-Pharmacy Service Providence Rhode Island 02903 —
Rhode Island Hospital Providence Rhode Island 02903 —
The Miriam Hospital Providence Rhode Island 02906 —
Medical University of South Carolina Lifespan Comprehensive Sickle Cell Center Charleston South Carolina 29425 —
Medical University of South Carolina-Hospital Charleston South Carolina 29425 —
Medical University of South Carolina Charleston South Carolina 29425 —
MUSC Investigational Drug Services Charleston South Carolina 29425 —
Cook Children's Hematology and Oncology Center Fort Worth Texas 76104 —
Cook Children's Medical Center Fort Worth Texas 76104 —
Cook Children's Hematology and Oncology Center-Grapevine Grapevine Texas 76051 —
University of Texas Medical School Houston Texas 77030 —
Primary Children's Hospital Laboratory Salt Lake City Utah 84113 —
Primary Children's Hospital Salt Lake City Utah 84113 —
Main Hospital-VCU Richmond Virginia 23298 —
Virginia Commonwealth University - Investigational Drug Services Richmond Virginia 23298 —
Virginia Commonwealth University- Clinical Research Services Unit Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02433158, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2021 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02433158 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →